Clinical trial

The Effect of Pramlintide on Meal Time Insulin Bolus

NCT00460304

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-09-01

PhaseNA

Study timeline

Study start (unknown)2007-09-01Date precision: month

Registry last updated2009-04-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

pramlintideDRUG · verified · RxNorm: pramlintide

continuous glucose monitoringPROCEDURE

Sponsors & collaborators

Diabetes Care Centerlead sponsor

Amylin Pharmaceuticals, LLC.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00460304 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.